Advantage of ReBOSSIS
- Handling Ability
- Moldability
- Fluid Absorption and Retention
- Osteogenic Potential
- Bioresorbability
Innovative
bone-void-filling material
ReBOSSIS History up to Commercialization
(Development Story)
Products are sold on consignment to
USA『ReBOSSIS®』: KYOCERA Medical Technologies, Inc.
Orthopedic Surgery in Japan『ReBOSSIS-J®』 : TEIJIN NAKASHIMA MEDICAL CO.,LTD.
Maxillofacial and Plastic Surgery in Japan 『ReBOSSIS-MS』: SHOFU Inc.
Maxillofacial and Plastic Surgery in Japan 『ReBOSSIS-MT』: TEIJIN MEDICAL TECHNOLOGY CO., LTD.
Maxillofacial and Plastic Surgery in Japan 『ReBOSSIS-MK』: Kyocera Corporation

■For Orthopedic Surgery Bone-void Filler
Product Information: ReBOSSIS
Country of Sales: USA
Approval Number(FDA 510(k)・Medical Device)K170620(Trauma), K172573(Spine)
Approval Date: June 2017 (Trauma), December 2017 (Spine)
Brand Name: ReBOSSIS
Distributor
KYOCERA Medical Technologies, Inc.
Product Information: ReBOSSIS-J
Country of Sales: Japan
Approval Number(Medical Device)30300BZX00095000
Approval Date: March 29th ,2021
Brand Name: ReBOSSIS-J
For inquiries, Contact
TEIJIN NAKASHIMA MEDICAL CO.,LTD.
688-1 Joto-Kitagata, Higashi-ku, Okayama 709-0625, Japan
TEL:086-279-6278
FAX:086-279-9510